首页> 美国卫生研究院文献>Therapeutic Advances in Neurological Disorders >Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

【2h】

Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

机译：患者以前用Cladribine片剂治疗的患者的长期有效性：对意大利多发性硬化登记处的实际分析（ClarInet-MS）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Therapeutic Advances in Neurological Disorders
作者
Francesco Patti; Andrea Visconti; Antonio Capacchione; Sanjeev Roy; Maria Trojano;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类神经科学;
关键词

机译：Cladribine片剂;临床上孤立综合征;有效性;长期数据;多发性硬化;现实世界数据;现实世界的证据;登记处;复发 - 汇编MS;

相似文献

外文文献
中文文献
专利

1. Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS) [J] . Francesco Patti, Andrea Visconti, Antonio Capacchione, Therapeutic advances in neurological disorders. . 2020,第6期

机译：患者以前用Cladribine片剂治疗的患者的长期有效性：对意大利多发性硬化登记处的实际分析（ClarInet-MS）
2. CLARITY: An Analysis of Severity and Frequency of Relapses in Patients with Relapsing-remitting Multiple Sclerosis Treated with Cladribine Tablets or Placebo [J] . Schippling S., Sormani M. P., De Stefano N., Multiple sclerosis: clinical and laboratory research . 2019,第3期

机译：清晰度：用克兰汀片或安慰剂治疗复发复杂多发性硬化症患者的严重程度和频率分析
3. Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis. [J] . Giovannoni G, Cook S, Rammohan K, Lancet Neurology . 2011,第4期

机译：CLARITY研究中使用克拉屈滨片治疗的复发缓解型多发性硬化症患者的持续无病活动状态：事后分析和亚组分析。
4. Time and time-frequency analysis of near-infrared signals for the assessment of ozone autohemotherapy long-term effects in multiple sclerosis [C] . Lintas, G., Molinari, F., Simonetti, V., Annual Conference of Japanese Society for Medical and Biological Engineering;Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2013

机译：近红外信号的时间和时频分析，用于评估多发性硬化症中臭氧自血疗法的长期影响
5. Aging and Disease-modifying Therapies in Multiple Sclerosis: Insights from Clinical Trials and Registries [D] . Zhang, Yinan. 2021

机译：多发性硬化症中的衰老和疾病改性疗法：临床试验和注册管理机构的见解
6. Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study [O] . Giancarlo Comi, Stuart Cook, Kottil Rammohan, 2018

机译：克拉屈滨片对复发缓解型多发性硬化症患者MRI活动结局的长期影响：CLARITY Extension研究
7. Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. [O] . De Stefano, N, Giorgio, A, Battaglini, M, 2017

机译：用克拉屈滨片治疗的复发性多发性硬化症患者，脑萎缩率降低与残疾进展风险降低相关。

Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

著录项

引文网络

相似文献

相关主题

期刊订阅